Levetiracetam as an alternative therapy for Tourette syndrome.

Neuropsychiatric Disease and Treatment
M A Martínez-GraneroF Montañes

Abstract

Tourette syndrome is a common childhood-onset neuropsychiatric disorder characterized by chronic tics and frequent comorbid conditions such as attention deficit disorder. Most currently used tic-suppressing drugs are frequently associated with serious adverse events. Thus, alternative therapeutic agents with more favorable side-effect profiles are being evaluated. New hypotheses and recent studies involving GABAergic system in the pathophysiology of Tourette syndrome suppose a reason for the evaluation of GABAergic drugs. Levetiracetam is a drug with an atypical GABAergic mechanism of action that might be expected to improve tics. Although trials performed to evaluate the efficacy of levetiracetam in the treatment of Tourette syndrome have provided conflicting results, it may be useful in some patients. The established safe profile of levetiracetam makes this drug an alternative for treatment if intolerance to currently used drugs appears, but additional evaluation with larger and longer duration controlled studies are necessary to assess the real efficacy in patients with Tourette syndrome.

References

Apr 1, 1991·Archives of General Psychiatry·J F LeckmanD J Cohen
Jul 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·J F LeckmanD J Cohen
Jan 1, 1993·The American Journal of Psychiatry·J F LeckmanD J Cohen
May 26, 1999·Journal of Child Neurology·Y Awaad
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K M CrowderS M Bajjalieh
May 10, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·B Kadesjö, C Gillberg
Sep 6, 2000·Developmental Medicine and Child Neurology·R D FreemanP Sandor
Mar 10, 2001·The Journal of Clinical Psychiatry·R BruggemanJ A Temlett
May 31, 2001·The Journal of Clinical Psychiatry·C L BudmanR D Bruun
Jan 19, 2002·Journal of Clinical Psychopharmacology·Yves DionGuy Chouinard
Feb 28, 2002·Neurology·UNKNOWN Tourette's Syndrome Study Group
Mar 7, 2002·Epilepsia·E H KossoffE P Vining
Mar 19, 2002·Neuropharmacology·P Poulain, D G Margineanu
Aug 15, 2002·Neurology·R KurlanM P McDermott
Nov 22, 2002·Lancet·James F Leckman
Apr 12, 2003·Neurology·L ScahillB S Peterson
Jul 29, 2003·Journal of Neurology·Alfredo BerardelliMario Manfredi
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Berkley A LynchBruno Fuks
Jul 13, 2004·Schizophrenia Research·Jonathan M Meyer, Carol E Koro
Sep 16, 2004·The Journal of Clinical Psychiatry·Naomi M SimonMark H Pollack
Feb 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Yasser AwaadSarah Minarik
Feb 22, 2005·Lancet Neurology·Harvey S Singer
Sep 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Paul S A KalanithiFlora M Vaccarino
Dec 5, 2006·CNS Drugs·Anjana Muralidharan, Zubin Bhagwagar
Mar 6, 2007·Journal of the Neurological Sciences·Dustin Y YoonHarvey S Singer
Jun 15, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Constance L Smith-HicksHarvey S Singer
Jul 17, 2008·Current Psychiatry Reports·Michael H Bloch
Jan 27, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·David Shprecher, Roger Kurlan
Feb 13, 2009·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Alberto Fernández-JaénBeatriz Calleja-Pérez
Mar 7, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Muhammad U FarooqMounzer Y Kassab
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Tamara Pringsheim, Connie Marras
May 13, 2009·Pediatric Neurology·Erika F HedderickHarvey S Singer
Jul 25, 2009·Journal of the American Academy of Child and Adolescent Psychiatry·Michael H BlochJames F Leckman
Aug 15, 2009·Lancet Neurology·Joseph Jankovic
Sep 4, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·J JankovicL W Brown

❮ Previous
Next ❯

Citations

Nov 26, 2015·Research in Developmental Disabilities·Wong Lee ChinShinn-Ying Ho
Dec 3, 2011·General Hospital Psychiatry·Michele FornaroLiliana Dell'Osso
Jun 5, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N A ErmolenkoE I Zakharova
Jan 26, 2020·Journal of Basic and Clinical Physiology and Pharmacology·Anisyah AchmadLaksmi Sasiarini
Aug 18, 2020·Journal of Neurology·James PetersHeather Angus-Leppan
Oct 15, 2014·ACS Medicinal Chemistry Letters·Hancheng CaiHarry T Chugani

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

YGTSS

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

Therapeutic Advances in Neurological Disorders
Clare M EddyAndrea E Cavanna
Journal of Psychosomatic Research
Michael H Bloch, James F Leckman
JAMA : the Journal of the American Medical Association
John PiacentiniJohn T Walkup
International Review of Neurobiology
Andrea E Cavanna, Andrea Nani
© 2021 Meta ULC. All rights reserved